Shandong Xinhua Pharmaceutical Company  

(Public, HKG:0719)   Watch this stock  
Find more results for 0719
+0.14 (1.88%)
Feb 15 - Close
HKG data delayed by 15 mins - Disclaimer
Currency in HKD
Range 7.51 - 7.60
52 week 5.69 - 10.28
Open 7.51
Vol / Avg. 190,000.00/727,147.00
Mkt cap 6.22B
P/E 13.59
Div/yield 0.04
EPS 0.56
Shares 150.00M
Beta     -
Inst. own     -
Mar 26, 2018
Q4 2017 Shandong Xinhua Pharmaceutical Co Ltd Earnings Release Add to calendar
Dec 22, 2017
Shandong Xinhua Pharmaceutical Co Ltd Extraordinary Shareholders Meeting

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 6.57% 3.31%
Operating margin 4.58% 3.67%
EBITD margin - 11.35%
Return on average assets 5.44% 2.89%
Return on average equity 12.40% 6.31%
Employees 6,346 -
CDP Score - -


No.1 Lutai Avenue, High-tech Zone
ZIBO, SDG 255086
+86-533-2166666 (Phone)
+86-533-2287508 (Fax)

Website links


SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED is a China-based company principally engaged in the development, production and distribution of chemical bulk drugs, preparations and medical intermediates. The Company’s main products include metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, L-dopa, pipemidic acid tablets, compound liquorice tablets and nimodipine tablets. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and others.

Officers and directors

Daiming Zhang Chairman of the Board
Age: 52
Ning Hou Chief Financial Officer
Age: 42
Xuejie Dou Deputy General Manager
Age: 55
Deqing Du Deputy General Manager
Age: 50
Tongqing He Deputy General Manager
Age: 44
Chit Fun So Financial Controller, Company Secretary
Age: 45
Deping Du Executive Director, General Manager
Age: 45
Xiaolong Wang Deputy General Manager
Age: 50
Fulong Ren Non-Executive Director
Age: 52
Lie Xu Non-Executive Director
Age: 49